Related Experiment Video

Updated: Jul 17, 2026

Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats
09:37

Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats

Published on: August 1, 2018

Cardiac dysfunction in cirrhosis

Ralph F Lee1, Tamara K Glenn, Samuel S Lee

  • 1Liver Unit, University of Calgary, Calgary, AB, Canada.

Best Practice & Research. Clinical Gastroenterology
|January 16, 2007
PubMed

Insights

Cirrhosis causes cardiac abnormalities, termed cirrhotic cardiomyopathy, affecting heart function and electrical stability. Understanding its mechanisms is key for managing liver disease complications.

Area of Science:

  • Cardiology
  • Hepatology
  • Pharmacology

Background:

  • Cirrhosis is linked to cardiovascular issues like increased cardiac output and reduced arterial pressure.
  • Patients with cirrhosis exhibit impaired systolic and diastolic function under stress, alongside electrical abnormalities like QT prolongation.
  • These cardiac dysfunctions are collectively known as cirrhotic cardiomyopathy.

Purpose of the Study:

  • To review the clinical features of cirrhotic cardiomyopathy.
  • To discuss the pathogenic mechanisms underlying this condition.
  • To explore the clinical consequences and management strategies for cirrhotic cardiomyopathy.

Main Methods:

  • This is a review article.
  • It synthesizes existing literature on cirrhotic cardiomyopathy.
  • Key pathogenic mechanisms and clinical implications are discussed.

Main Results:

  • Cirrhotic cardiomyopathy involves impaired beta-adrenergic signaling, cardiomyocyte membrane dysfunction, altered calcium kinetics, and humoral factors.
  • It contributes to cardiac dysfunction post-transjugular intrahepatic portosystemic stent-shunt insertion and liver transplantation.
  • It may also play a role in hepatorenal syndrome development.

Conclusions:

  • Cirrhotic cardiomyopathy is a significant complication of cirrhosis with diverse pathogenic mechanisms.
  • It impacts patient outcomes, particularly after procedures like liver transplantation.
  • Further research into management options is warranted.

Related Concept Videos

Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...